Botulinum toxin type a is a safe and effective treatment for neurogenic urinary incontinence: results of a single treatment, randomized, placebo controlled 6-month study.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

We determined the safety and efficacy of each of 2 doses of botulinum toxin type A (BTX-A) (200 or 300 U BOTOX) injected into the detrusor for urinary incontinence caused by neurogenic detrusor overactivity of predominantly spinal cord origin.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): J. Urol.

Title: The Journal of urology

Publisher: Ovid Technologies (Wolters Kluwer Health)

ISSN: 0022-5347

ISSN (Print): 0022-5347

Publication date (Electronic): Jul 2005

Volume: 174

Issue: 1

Affiliations

[1 ] Spinal Cord Injury Centre, University Hospital Balgrist, Zurich, Switzerland. schurdhb@balgrist.unizh.ch

Article

Publisher Item ID: S0022-5347(05)60066-3

DOI: 10.1097/01.ju.0000162035.73977.1c

PubMed ID: 15947626

SO-VID: c8816bde-bdd7-4049-b09e-5e4ed811c669

History

Data availability:

Comments

Comment on this article

scite_

0

Smart Citations

0

Citing PublicationsSupportingMentioningContrasting

View Citations

See how this article has been cited at scite.ai

scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.